The first half of 2025 is redefining the contours of global mergers and acquisitions. A cluster of landmark transactions — spanning semiconductors, life sciences, defense technology, and energy infrastructure — signals that strategic acquirers and private equity firms are deploying capital with renewed conviction. With over $27 billion in announced deal value across just a handful of transactions this week alone, the message to CFOs, General Counsel, and M&A Directors is unambiguous: the window for transformative deals is open, but execution risk has never been higher.

AI and Deep Tech Are Rewriting Semiconductor M&A Valuations

ON Semiconductor’s $7 billion all-stock acquisition of Synaptics — its largest deal to date — is emblematic of a broader structural shift in corporate finance strategy. The transaction is not simply a capacity play; it is a deliberate repositioning toward AI-enabled edge devices and physical AI technologies, a segment where hardware-software convergence is generating premium valuations.

Simultaneously, CoreWeave’s $9 billion offer for Core Scientific — currently facing material shareholder resistance — illustrates the growing tension between strategic ambition and market discipline in large-scale tech infrastructure acquisitions. Regulatory and shareholder scrutiny on mega-tech transactions is intensifying, particularly where deal structures rely heavily on equity and where synergy assumptions are difficult to stress-test.

For M&A Directors evaluating targets in the AI and semiconductor space, several due diligence imperatives follow:

  • IP ownership and licensing chains must be mapped with precision, especially where AI model training data intersects with third-party rights.
  • Export control compliance under U.S. EAR and EU dual-use regulations is non-negotiable in any cross-border semiconductor deal.
  • Post-merger integration of engineering cultures — particularly between hardware-centric and software-first organizations — requires dedicated workstreams from day one of exclusivity.

European Strategic Capital Moves: Life Sciences and Defense Consolidation

From a European perspective, two transactions stand out for their strategic and regulatory implications. Merck KGaA’s $11.3 billion acquisition of Bio-Techne — its most significant deal in over a decade — reflects the German pharma and life sciences giant’s intent to scale its tools and services platform in the U.S. market. Cross-border deals of this magnitude between EU-headquartered acquirers and U.S. targets will face heightened scrutiny under both the EU Foreign Subsidies Regulation (FSR) and U.S. CFIUS review, particularly given Bio-Techne’s exposure to government-funded research contracts.

In parallel, Safran’s entry into exclusive negotiations to acquire Exail Technologies at €128.5 per share underscores the accelerating consolidation of European defense technology. As NATO member states increase defense spending toward and beyond the 2% GDP threshold, prime contractors are racing to internalize autonomous systems and maritime drone capabilities. For General Counsel advising on European defense M&A, the interplay between French strategic investment screening (under the décret Montebourg framework) and EU defense industrial policy adds a layer of jurisdictional complexity that demands early-stage regulatory mapping.

Private Equity and the Energy Infrastructure Opportunity

KKR’s acquisition of EDF Power Solutions in the U.S. and Canada from EDF Group reflects a well-established private equity thesis: utilities and energy majors under balance sheet pressure are natural divestiture candidates, and infrastructure assets with contracted cash flows command strong valuations in the current rate environment. Cross-border PE deals in the energy sector are being shaped by three converging forces — the energy transition, grid modernization mandates, and the need for industrial decarbonization financing.

For boards and CFOs evaluating similar carve-out or divestiture opportunities, the KKR-EDF transaction offers a structural reference point: clean separation of regulated and unregulated assets, robust transitional service agreements, and alignment with host-country energy security frameworks are prerequisites for a smooth close.

Implications for Decision-Makers

The current deal environment rewards preparation and penalizes improvisation. Whether you are a strategic acquirer in semiconductors, a European life sciences company pursuing U.S. scale, or a private equity firm evaluating energy infrastructure, the following principles apply:

  • Regulatory pre-clearance strategy should be integrated into deal structuring, not treated as a post-signing formality.
  • Shareholder communication on deal rationale and synergy delivery timelines is increasingly a determinant of deal success, as the CoreWeave situation demonstrates.
  • Post-merger integration planning must begin during due diligence — technology, talent, and compliance workstreams in particular cannot wait for Day 1.

Key Takeaway: The $27B+ in deal activity announced this week reflects a market where AI capability, defense sovereignty, and energy transition are the primary drivers of strategic M&A. For European and global decision-makers, the competitive advantage lies not in deal volume, but in the quality of due diligence, the rigor of integration planning, and the sophistication of cross-border regulatory navigation.